Assessment of clinical outcomes with immune checkpoint inhibitor therapy in melanoma patients with CDKN2A and TP53 pathogenic mutations

Thomas T. DeLeon, Daniel R. Almquist, Benjamin R. Kipp, Blake T. Langlais, Aaron Mangold, Jennifer L. Winters, Heidi E. Kosiorek, Richard W. Joseph, Roxana S. Dronca, Matthew S. Block, Robert R. McWilliams, Lisa A. Kottschade, Kandelaria M. Rumilla, Jesse S. Voss, Mahesh Seetharam, Aleksandar Sekulic, Svetomir N. Markovic, Alan H. Bryce

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Assessment of clinical outcomes with immune checkpoint inhibitor therapy in melanoma patients with CDKN2A and TP53 pathogenic mutations'. Together they form a unique fingerprint.

Agriculture & Biology

Medicine & Life Sciences

Chemical Compounds